BioWorld

Dec. 28, 2006

CombiMatrix Breaks From Acacia, To List On AMEX

Biotech tools company CombiMatrix Corp. has filed to list its stock on the American Stock Exchange in a move to separate itself from parent Acacia Research Corp. (BioWorld Today) Read More

AstraZeneca Goes Forward With AZD3480; Targacept Gets $20M

Fighting 'Gang Of Four' Is Uphill Battle, But Success Stories Exist

Placement Gives Callisto Funds For Clinical-Stage Cancer Drugs

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 16, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 16, 2026.

SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

BioWorld Science

Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...